BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16215446)

  • 21. Cost savings from home and community-based services: Arizona's capitated Medicaid long-term care program.
    Weissert WG; Lesnick T; Musliner M; Foley KA
    J Health Polit Policy Law; 1997 Dec; 22(6):1329-57. PubMed ID: 9459131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating selection out of health plans for Medicaid beneficiaries with substance abuse.
    Normand SL; Belanger AJ; Frank RG
    J Behav Health Serv Res; 2003; 30(1):78-92. PubMed ID: 12633005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric service utilization and cost for persons with schizophrenia in a Medicaid managed care program.
    Rothbard AB; Kuno E; Hadley TR; Dogin J
    J Behav Health Serv Res; 2004; 31(1):1-12. PubMed ID: 14722476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Here's how to evaluate state Medicaid cap rates--before signing on the dotted line.
    Public Sect Contract Rep; 1997 Sep; 3(9):140-2. PubMed ID: 10174886
    [No Abstract]   [Full Text] [Related]  

  • 25. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-site study of Medicaid-funded managed care versus fee-for-service plans' effects on mental health service utilization of children with severe emotional disturbance.
    Cook JA; Heflinger CA; Hoven CW; Kelleher KJ; Mulkern V; Paulson RI; Stein-Seroussi A; Fitzgibbon G; Burke-Miller J; Williams M; Kim JB
    J Behav Health Serv Res; 2004; 31(4):384-402. PubMed ID: 15602140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of capitated financing on psychiatric emergency services.
    Catalano RA; Coffman JM; Bloom JR; Ma Y; Kang SH
    Psychiatr Serv; 2005 Jun; 56(6):685-90. PubMed ID: 15939944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mental health/substance abuse treatment in managed care: the Massachusetts Medicaid experience.
    Callahan JJ; Shepard DS; Beinecke RH; Larson MJ; Cavanaugh D
    Health Aff (Millwood); 1995; 14(3):173-84. PubMed ID: 7498890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution in a Medicaid mental health carve-out: services and costs.
    Libby AM; Cuellar A; Snowden LR; Orton HD
    J Health Care Finance; 2002; 28(4):11-23. PubMed ID: 12148661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does capitation affect the health of the chronically mentally ill? Results from a randomized trial.
    Lurie N; Moscovice IS; Finch M; Christianson JB; Popkin MK
    JAMA; 1992 Jun; 267(24):3300-4. PubMed ID: 1597911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Oregon experience. Must doctors lose money with managed Medicaid?
    Collins C
    Manag Care; 1997 Nov; 6(11):45-6, 49-50. PubMed ID: 10176722
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state.
    Wickizer TM; Krupski A; Stark KD; Mancuso D; Campbell K
    Milbank Q; 2006; 84(3):555-76. PubMed ID: 16953810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health outcomes and medicaid costs for frail older individuals: a case study of a MCO versus fee-for-service care.
    Burton LC; Weiner JP; Stevens GD; Kasper J
    J Am Geriatr Soc; 2002 Feb; 50(2):382-8. PubMed ID: 12028225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An examination of state Medicaid financing arrangements for early childhood development services.
    Fox HB; McManus MA; Limb SJ
    Matern Child Health J; 2000 Mar; 4(1):19-27. PubMed ID: 10941757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing Medicaid behavioral health care: findings of a national survey in the year 2000.
    Ridgely MS; Maglione MA
    Psychiatr Serv; 2006 Jul; 57(7):1000-6. PubMed ID: 16816285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance abuse treatment duration for Medicaid versus commercial clients in a health maintenance organization.
    McFarland BH; Lynch FL; Freeborn DK; Green CA; Polen MR; Deck DD; Dickinson DM
    Med Care; 2006 Jun; 44(6):601-6. PubMed ID: 16708010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Iowa Managed Substance Abuse Care Plan: access, utilization, and expenditures for Medicaid recipients.
    McCarty D; Argeriou M
    J Behav Health Serv Res; 2003; 30(1):18-25. PubMed ID: 12633002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of drug treatment of childhood persistent asthma in Maryland medicaid recipients in transition from managed fee for service to managed capitation.
    Singhal PK; Zuckerman I; Stuart B; Magder L; Rubin H
    J Manag Care Pharm; 2007 May; 13(4):310-8. PubMed ID: 17506597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public managed care and service access in outpatient substance abuse treatment units.
    Chuang E; Wells R; Alexander JA
    J Behav Health Serv Res; 2011 Oct; 38(4):444-63. PubMed ID: 21184286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of the Utah Prepaid Mental Health Plan on structure, process, and outcomes of care.
    Lurie N; Christianson JB; Gray DZ; Manning WG; Popkin MK
    New Dir Ment Health Serv; 1998; (78):99-106. PubMed ID: 9658859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.